Stocks / NASDAQ / Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd.

Our Opinion

Scinai Immunotherapeutics Ltd. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

“Scinai has previously demonstrated the potential of its NanoAbs as therapeutically viable molecules in COVID-19 animal studies. These studies showed that the Company’s inhaled COVID-19 NanoAb therapy resulted in milder and shorter illness, virtually eliminated the virus from the lungs, and prophylactically protected against illness at commercially viable dose levels.” Read the following article

Company Description

Scinai Immunotherapeutics Ltd. operates as a biopharmaceutical company. The Company focuses on developing, manufacturing, and commercializing inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. Scinai Immunotherapeutics serves customers worldwide.

Company Website: